Should the FDA Have Approved Remdesivir?

Full FDA approval means remdesivir is now the standard of care for hospitalized patients, and now other potential treatments will have to go toe-to-toe with it during clinical research. Before it received approval, the WHO announced preliminary results that the drug had no effect on mortality, and negligible effects on how long a patient remained in the hospital. Researchers are now claiming there wasn’t enough data for full approval, and want the FDA to pump the breaks in the absence of a vaccine.